G2H-CVD1.0

G2H-CVD1.0

  • 库存100
  • 产地Online
  • 数量
详情

Welcome to G2H-CVD1.0 - Predict Your 10-Year Cardiovascular Disease Risk

At G2H, we believe in empowering individuals to take control of their heart health with cutting-edge tools. Our G2H-CVD1.0 is a powerful risk prediction model designed to assess your 10-year risk of developing cardiovascular disease (CVD).

How It Works:

  1. Simple Inputs: Enter your basic health information, such as age, sex, cholesterol levels, blood pressure, and lifestyle factors.
  2. Advanced Predictive Model: Using state-of-the-art algorithms, G2H-CVD1.0 analyzes your data to generate a personalized risk assessment for cardiovascular disease over the next 10 years.
  3. Get Your Free Report: Once you complete the input, you will receive a detailed risk prediction report along with personalized recommendations to improve your heart health.

Why Use G2H-CVD1.0?

  • Accurate Predictions: G2H-CVD1.0 uses scientifically validated models to give you a reliable prediction.
  • Personalized Recommendations: Based on your results, you’ll get tailored suggestions to improve your health.
  • Completely Free: No hidden costs or requirements, just input your details and get your risk report.

Start Your Risk Prediction Today:

Click on the button below to get started with the G2H-CVD1.0 prediction tool.

Try G2H-CVD1.0 Now

https://g2h.lanechen.xyz

    G2H - G2H Platform (gene2h.com) 是本公司主打的皇牌产品,可供Bussiness客户使用,也可由个人消费者直接上传DNA数据使用。

    您的DNA数据可以从您的基因检测服务商处索取,比如23AndMe, WeGene等。


    已经做过基因检测?如何获取你的数据以上传?


    Upload your raw DNA data from genetic testings like AncestryDNA23andMe, or MyHeritage etc. to get additional DNA analysis. 

    300+ weekly expanding unique traits, health research, disease risk analysis and more. Go beyond ancestry at G2H - G2H Platform (gene2h.com) !


    G2H中文版
    基因智健(创思健康科技旗下产品)是目前最前沿的智能健康风险预测管理平台
    发表评论
    评论通过审核后显示。
    热门产品 Best Sellers
    • 4754 G2H
    • G2H (developed by CHONPS Health Tech) is the most
    • 4527 G2H中文版
    • 基因智健(创思健康科技旗下产品)是目前最前沿的智能健康风险预测管理平台
    公司简介

    Gene to Health Limited primarily focuses on developing multi-omics predictive models for common disease risks, conducting biomedical big data analysis and modeling, and providing bioinformatics research services.  We are a pioneer in Asia focused on polygenic scoring technology, leveraging millions of disease-related genetic variants and other omics data to predict over 1000 traits and diseases. Our core product suite, G2H, provides personalized health management solutions in one platform, including risk assessments for chronic diseases, dietary optimization, lifestyle advisory, and cancer risk prediction. We aim to revolutionize disease prevention and improve early disease intervention by integrating advanced genomic analysis, ML and AI.

    我们是来自香港大学医学院 (HKU Med) 的博士创业团队,拥有以Polygenic Scoring (多基因风险评分,PGS)的核心技术,基因智健(G2H)平台是我们开发的核心产品。该平台主要利用基于多组学大数据的统计机器学习模型分析用户数据,从而预测和评估上千种种人类疾病风险和健康表型,为您的健康人生保驾护航。

    联系我们
    聯繫人: Dr. CHEN Guolan Lane
    電話: +852 46404365
    Email: support@gene2h.com
    QQ: 3028035047
    微信: lanechenhku
    微博: u/7735987435
    地址: 1)Unit 707-34, 7F, Building 19W, No. 19 Science Park West Avenue, Hong Kong Science and Technology Park, Pak Shek Kok, N.T., Hong Kong 2)5 Sassoon Road, 1F, Pok Fu Lam, Hong Kong, China 3)Room 903, No. 91, Ke Feng Road, Huangpu District (Guangzhou Development Zone), Guangzhou, Guangdong Province, China 1)中国香港特别行政区新界白石角科技园西大道19号19W座7楼707-34单元 2)中国香港特别行政区薄扶林沙宣道5号1F 3)中国广东省广州市黄埔区(广州开发区)科丰路91号903
    即时咨询

    扫一扫企业微信客服,立即与我们沟通 (WeChat Customer Service)

    Follow us at LinkedIn 关注领英